文献速递心脑血管急症复苏、休克与脓毒症

人工智能辅助心电图衍生序贯规则决策树排除急性冠脉综合征作为院外心脏骤停病因:单中心回顾性队列研究

Artificial Intelligence-Assisted, Electrocardiogram-Derived, Sequential Rule-Based Decision Tree for Exclusion of Acute Coronary Syndrome as the Etiology of Out-of-Hospital Cardiac Arrest: A Single-Center Retrospective Cohort Study.
PubMed 文献 · Resuscitation · 2026-10-29
一句话结论在ROSC后OHCA患者中,一种心律分层的AI心电图决策树可将约半数患者判为「ACS不太可能」,无漏诊ACS,主要见于非可除颤心律亚组。

本研究为单中心回顾性队列研究,纳入成人OHCA患者,开发队列329例(2020-2024),时间验证队列71例(2025)。决策树在开发队列和验证队列分别将171/329(52.0%)和32/71(45.1%)判为「ACS不太可能」,无任何经判定的ACS病例被误分类;排除产出集中在非可除颤亚组(排除169/261非ACS病例,64.8%,AUROC 0.824),可除颤亚组中38/40(95.0%)保留为「ACS未排除」。该框架透明、床旁可部署,但尚需前瞻性多中心评估。

要点

  • 心律分层的AI心电图序贯决策树在零假阴性约束下开发:开发队列52.0%、验证队列45.1%的ROSC后OHCA患者被判为「ACS不太可能」,无判定ACS病例被误分类。
  • 排除产出集中在非可除颤心律亚组:该亚组排除169/261(64.8%)非ACS病例,AUROC 0.824,优于各单个生物标志物。
  • 可除颤心律亚组ACS验前概率高:38/40(95.0%)患者被保留为「ACS未排除」,该亚组不适用此排除策略。
  • 该工具为单中心回顾性开发与时间验证,尚不能替代急诊冠脉造影决策,需前瞻性多中心评估。

适用人群与场景

  • 成人院外心脏骤停(OHCA)患者,ROSC后接受12导联心电图分析者;开发队列为2020-2024年n=329,时间验证队列为2025年n=71。

诊断标准与关键阈值

  • 输出分类为「ACS不太可能」与「ACS未排除」;原文未提及具体评分界值或阈值。

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 可除颤心律亚组ACS验前概率高,38/40(95.0%)被保留为「ACS未排除」,不能依据该决策树排除ACS。
  • 任何经判定的ACS病例在决策树各节点均未被误分类(零假阴性约束),但该性能需前瞻性验证。

研究设计与关键结果

  • 主要结果:决策树将开发队列171/329(52.0%)和验证队列32/71(45.1%)判为「ACS不太可能」,无任何经判定的ACS病例被误分类。
  • 非可除颤亚组:排除169/261(64.8%)非ACS病例,AUROC 0.824,优于每个单个生物标志物。
  • 可除颤亚组:38/40(95.0%)患者保留为「ACS未排除」。

证据类型、等级与局限

  • 证据类型:单中心回顾性队列研究,含开发队列与时间验证队列。
  • 局限:单中心、回顾性设计、样本量有限(开发n=329,验证n=71),需前瞻性多中心评估。

对床旁实践的改变

  • 对于ROSC后OHCA且无ST段抬高的患者,尤其非可除颤心律者,该AI心电图决策树可辅助识别「ACS不太可能」的人群(开发队列52.0%、验证队列45.1%),但尚不能据此常规取消急诊冠脉造影。
  • 可除颤心律亚组不适用该排除策略(95.0%被保留为「ACS未排除」)。
  • 常见陷阱:将回顾性单中心模型的排除产出误当作前瞻性验证的决策阈值;原文强调需前瞻性多中心评估。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

BACKGROUND: After out-of-hospital cardiac arrest (OHCA) with return of spontaneous circulation (ROSC), deciding which patients without ST-segment elevation warrant emergency coronary angiography is difficult, as standard electrocardiogram (ECG), troponin, and echocardiography are limited in the early post-arrest window. We aimed to develop a sequential rule-based decision tree to identify post-ROSC patients in whom acute coronary syndrome (ACS) is unlikely to be the arrest etiology.

METHODS: In this single-center retrospective study, adult patients with OHCA were divided into development (2020-2024; n=329) and temporal validation (2025; n=71) cohorts. Post-ROSC 12-lead ECGs were analyzed by a deep-learning platform generating ten digital biomarkers. Five candidate biomarkers were combined into a rhythm-stratified sequential decision tree under a zero false-negative constraint; its performance was compared with that of individual biomarkers and validated in the temporal cohort.

RESULTS: The tree classified 171/329 (52.0%) and 32/71 (45.1%) patients in the development and validation cohorts, respectively, as "ACS not likely," with no adjudicated ACS case misclassified at any node. Yield concentrated in the non-shockable subgroup, in which the model excluded 169/261 (64.8%) non-ACS cases (area under the receiver operating characteristic curve [AUROC], 0.824), outperforming each individual biomarker. In the shockable subgroup, which carries a high pretest probability of ACS, 38/40 patients (95.0%) were retained as "ACS not excluded."

CONCLUSIONS: A rhythm-stratified, rule-based decision tree combining AI-assisted ECG-derived biomarkers classified approximately half of post-OHCA patients as "ACS not likely" with no adjudicated ACS case misclassified, principally in the non-shockable subgroup. This transparent, bedside-deployable framework warrants prospective multicenter evaluation.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Choi A, Yoon H, Won Lee SG, et al. Artificial Intelligence-Assisted, Electrocardiogram-Derived, Sequential Rule-Based Decision Tree for Exclusion of Acute Coronary Syndrome as the Etiology of Out-of-Hospital Cardiac Arrest: A Single-Center Retrospective Cohort Study. Resuscitation. 2026. PMID: 42956925. doi:10.1016/j.resuscitation.2026.111373

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。